Dossier
Skinny Label
Coverage of Skinny Label in the Nexus archive.
- Supreme Court Backs Maker of Generic Heart Drug in 'Skinny Label' Case
The Supreme Court ruled that Amarin Pharma has not sufficiently proven that Hikma Pharmaceuticals' generic version of icosapent ethyl (Vascepa) infringes on its patents. The decision centers on a 'Skinny Label' case involving the heart drug.
- Supreme Court rules on fight between drugmakers in "skinny label" patent case
The Supreme Court ruled in favor of a generic drugmaker accused of infringing Amarin Pharma patents related to 'skinny labels.' The decision was reported by CBS News' Jan Crawford.